A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin

Summary

The purpose of this study is to evaluate the effect of lanabecestat on rosuvastatin. The amount of rosuvastatin in the blood will be compared, when taken alone, and then when taken with lanabecestat. The amount of lanabecestat that gets into the bloodstream will be measured. Information about any side effects that may occur will also be collected. Participants will be on study for 21 days with a follow-up at least 7 days afterwards. Screening will be undertaken within 45 days prior to enrollment.

Timeline

Start

2017-01-12

Primary completion

2017-05-22

Completion

2017-05-22

Drugs

Indications

No indication recorded.